Beta blocker (BB) use was associated with reduced atrial fibrillation (AF) and flutter (AFL) in the sudden cardiac death heart failure trial (SCD-HeFT)
Publication
, Conference
Dickinson, MG; Ip, JH; Hellkamp, AS; Anderson, J; Johnson, G; Singh, SN; Poole, JE; Mark, DB; Lee, K; Bardy, GH
Published in: CIRCULATION
October 31, 2006
Duke Scholars
Published In
CIRCULATION
ISSN
0009-7322
Publication Date
October 31, 2006
Volume
114
Issue
18
Start / End Page
375 / 375
Location
Chicago, IL
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Conference Name
79th Annual Scientific Session of the American-Heart-Association
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Dickinson, M. G., Ip, J. H., Hellkamp, A. S., Anderson, J., Johnson, G., Singh, S. N., … Bardy, G. H. (2006). Beta blocker (BB) use was associated with reduced atrial fibrillation (AF) and flutter (AFL) in the sudden cardiac death heart failure trial (SCD-HeFT). In CIRCULATION (Vol. 114, pp. 375–375). Chicago, IL: LIPPINCOTT WILLIAMS & WILKINS.
Dickinson, Michael G., John H. Ip, Anne S. Hellkamp, Jill Anderson, George Johnson, Steven N. Singh, Jeanne E. Poole, Daniel B. Mark, Kerry Lee, and Gust H. Bardy. “Beta blocker (BB) use was associated with reduced atrial fibrillation (AF) and flutter (AFL) in the sudden cardiac death heart failure trial (SCD-HeFT).” In CIRCULATION, 114:375–375. LIPPINCOTT WILLIAMS & WILKINS, 2006.
Dickinson MG, Ip JH, Hellkamp AS, Anderson J, Johnson G, Singh SN, et al. Beta blocker (BB) use was associated with reduced atrial fibrillation (AF) and flutter (AFL) in the sudden cardiac death heart failure trial (SCD-HeFT). In: CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2006. p. 375–375.
Dickinson, Michael G., et al. “Beta blocker (BB) use was associated with reduced atrial fibrillation (AF) and flutter (AFL) in the sudden cardiac death heart failure trial (SCD-HeFT).” CIRCULATION, vol. 114, no. 18, LIPPINCOTT WILLIAMS & WILKINS, 2006, pp. 375–375.
Dickinson MG, Ip JH, Hellkamp AS, Anderson J, Johnson G, Singh SN, Poole JE, Mark DB, Lee K, Bardy GH. Beta blocker (BB) use was associated with reduced atrial fibrillation (AF) and flutter (AFL) in the sudden cardiac death heart failure trial (SCD-HeFT). CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2006. p. 375–375.
Published In
CIRCULATION
ISSN
0009-7322
Publication Date
October 31, 2006
Volume
114
Issue
18
Start / End Page
375 / 375
Location
Chicago, IL
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Conference Name
79th Annual Scientific Session of the American-Heart-Association
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology